A phase 1b study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma
Mikhael, Joseph, Richardson, Paul, Usmani, Saad Z., Raje, Noopur, Bensinger, William, Karanes, Chatchada, Campana, Frank, Kanagavel, Dheepak, Dubin, Franck, Liu, Qianying, Semiond, Dorothée, Anderson, Kenneth
Published in Blood (11.07.2019)
Published in Blood (11.07.2019)
Get full text
Journal Article
Final results of a phase 1b study of isatuximab short-duration fixed-volume infusion combination therapy for relapsed/refractory multiple myeloma
Usmani, Saad Z., Karanes, Chatchada, Bensinger, William I., D’Souza, Anita, Raje, Noopur, Tuchman, Sascha A., Sborov, Douglas, Laubach, Jacob P., Bianchi, Giada, Kanagavel, Dheepak, Saleem, Rao, Dubin, Franck, Campana, Frank, Richardson, Paul G.
Published in Leukemia (01.12.2021)
Published in Leukemia (01.12.2021)
Get full text
Journal Article
Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis
Richardson, Paul G, Perrot, Aurore, Miguel, Jesus San, Beksac, Meral, Spicka, Ivan, Leleu, Xavier, Schjesvold, Fredrik, Moreau, Philippe, Dimopoulos, Meletios A, Huang, Shang-Yi, Minarik, Jiri, Cavo, Michele, Prince, H Miles, Macé, Sandrine, Zhang, Rick, Dubin, Franck, Morisse, Mony Chenda, Anderson, Kenneth C
Published in Haematologica (Roma) (01.07.2024)
Published in Haematologica (Roma) (01.07.2024)
Get full text
Journal Article
P931: ISATUXIMAB IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH ULTRA‐HIGH‐RISK CYTOGENETICS: ICARIA‐MM AND IKEMA SUBGROUP ANALYSIS
Moreau, Philippe, Perrot, Aurore, Dimopoulos, Meletios A., Martin, Thomas, Facon, Thierry, Eduardo Capra, Marcelo, Beksac, Meral, Armstrong, Nicole, Dubin, Franck, Macé, Sandrine, Risse, Marie‐Laure, Tekle, Christina, Klippel, Zandra, Richardson, Paul
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
Attal, Michel, Richardson, Paul G, Rajkumar, S Vincent, San-Miguel, Jesus, Spicka, Ivan, Leleu, Xavier, Schjesvold, Fredrik, Moreau, Philippe, Dimopoulos, Meletios A, Huang, Jeffrey Shang-Yi, Cavo, Michele, Prince, H Miles, Campana, Frank, Dubin, Franck, Attal, Michel, Rajkumar, Vincent, San-Miguel, Jesus, Beksac, Meral, Spicka, Ivan, Schjesvold, Fredrik, Moreau, Philippe, Dimopoulos, Meletios A., Minarik, Jiri, Cavo, Michele, Prince, H. Miles, Macé, Sandrine, Le-Guennec, Solenn, Dubin, Franck, Anderson, Kenneth C., Harrison, Simon, Janowski, Wojt, Kerridge, Ian, Delforge, Michel, Fostier, Karel, Vlummens, Philip, Wu, Ka Lung, Leblanc, Richard, Pavic, Michel, Sebag, Michael, Hajek, Roman, Maisnar, Vladimir, Gregersen, Henrik, Benbouker, Lotfi, Caillot, Denis, Facon, Thierry, Karlin, Lionel, Kolb, Brigitte, Pegourie, Brigitte, Tiab, Mourad, Vincent, Laure, Niederwieser, Dietger, Anagnostopoulos, Achilles, Delimpasi, Sosana, Symeonidis, Anargyros, Illes, Arpad, Mikala, Gabor, Corradini, Paolo, Fabio, Ciceri, Lemoli, Roberto, Liberati, Anna, Zambello, Renato, Iida, Shinsuke, Ikeda, Takashi, Iyama, Satoshi, Matsumoto, Morio, Sunami, Kazutaka, Suzuki, Kenshi, Uchiyama, Michihiro, Koh, Youngil, Kim, Kihyun, Lee, Jae Hoon, Min, Chang-Ki, Blacklock, Hillary, Goodman, Hugh, Neylon, Annette, Simpson, David, Grosicki, Sebastian, Jurczyszyn, Artur, Walter-Croneck, Adam, Araujo, Luis, Moreira, Claudia, Doronin, Vadim, Vranovsky, Andrej, Alegre, Adrian, Gonzalez Perez, Marta Sonia, Montes, Carmen, Ocio, Enrique, Rodriguez, Paula, Hardling, Mats, Lauri, Birgitta, Wang, Ming-Chung, Yeh, Su-Peng, Arat, Mutlu, Gulbas, Zafer, Karadogan, Ihsan, Tuglular, Tulin, Vural, Filiz, Sive, Jonathan, Yong, Kwee, Tache, Jason
Published in The Lancet (British edition) (07.12.2019)
Published in The Lancet (British edition) (07.12.2019)
Get full text
Journal Article
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study
Richardson, Paul G, Perrot, Aurore, San-Miguel, Jesus, Beksac, Meral, Spicka, Ivan, Leleu, Xavier, Schjesvold, Fredrik, Moreau, Philippe, Dimopoulos, Meletios A, Huang, Jeffrey Shang-Yi, Minarik, Jiri, Cavo, Michele, Prince, H Miles, Malinge, Laure, Dubin, Franck, van de Velde, Helgi, Anderson, Kenneth C
Published in The lancet oncology (01.03.2022)
Published in The lancet oncology (01.03.2022)
Get full text
Journal Article
Isatuximab
Wilmoth, Jenai, Colson, Kathleen, Dubin, Franck, Kellam, Christine
Published in Clinical journal of oncology nursing (01.12.2021)
Published in Clinical journal of oncology nursing (01.12.2021)
Get full text
Journal Article
Isatuximab: Nursing Considerations for Use in the Treatment of Multiple Myeloma
Wilmoth, Jenai, Colson, Kathleen, Dubin, Franck, Kellam, Christine
Published in Clinical journal of oncology nursing (01.12.2021)
Published in Clinical journal of oncology nursing (01.12.2021)
Get full text
Journal Article
Isatuximab Plus Pomalidomide/Low-Dose Dexamethasone Versus Pomalidomide/Low-Dose Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (ICARIA-MM): Characterization of Subsequent Antimyeloma Therapies
Richardson, Paul G., Perrot, Aurore, San-Miguel, Jesús, Beksac, Meral, Spicka, Ivan, Leleu, Xavier, Schjesvold, Fredrik, Moreau, Philippe, Dimopoulos, Meletios A., Huang, Jeffrey SY, Minarik, Jiri, Cavo, Michele, Prince, H. Miles, Macé, Sandrine, Malinge, Laure, Dubin, Franck, Morisse, Mony, Anderson, Kenneth C.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Ithaca Study
Mateos, Maria-Victoria, Rodriguez Otero, Paula, Koh, Youngil, Martinez-Lopez, Joaquin, Parmar, Gurdeep, Prince, H. Miles, Quach, Hang, Ribas, Paz, Hermansen, Emil, Hungria, Vania T.M., Besisik, Sevgi Kalayoglu, Kim, Jin Seok, Leleu, Xavier, Pečeliūnas, Valdas, Schjesvold, Fredrik, Sevindik, Omur G., Lavrova, Tatiana, Dubin, Franck, Devisme, Christine, Lepine, Lucie, Macé, Sandrine, Morisse, Mony, Ghobrial, Irene
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
MM-246 Isatuximab (Isa) in Relapsed Multiple Myeloma (MM) Patients (pts) With Ultra-High-Risk (UHR) Cytogenetics: ICARIA-MM and IKEMA Subgroup Analysis
Moreau, Philippe, Perrot, Aurore, Dimopoulos, Meletios-Athanasios, Martin, Thomas, Facon, Thierry, Capra, Marcelo, Beksac, Meral, Armstrong, Nicole M, Pharm, Franck Dubin, Macé, Sandrine, Risse, Marie-Laure, Tekle, Christina, Klippel, Zandra, Richardson, Paul G.
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
POSTER: MM-246 Isatuximab (Isa) in Relapsed Multiple Myeloma (MM) Patients (pts) With Ultra-High-Risk (UHR) Cytogenetics: ICARIA-MM and IKEMA Subgroup Analysis
Moreau, Philippe, Perrot, Aurore, Dimopoulos, Meletios-Athanasios, Martin, Thomas, Facon, Thierry, Capra, Marcelo, Beksac, Meral, Armstrong, Nicole M, Dubin, Franck, Macé, Sandrine, Risse, Marie-Laure, Tekle, Christina, Klippel, Zandra, Richardson, Paul G.
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
Updates from ICARIA-MM, a phase 3 study of isatuximab (Isa) plus pomalidomide and low-dose dexamethasone (Pd) versus Pd in relapsed and refractory multiple myeloma (RRMM)
Richardson, Paul G., Perrot, Aurore, F. San-Miguel, Jesús, Beksac, Meral, Spicka, Ivan, Leleu, Xavier, Schjesvold, Fredrik, Moreau, Philippe, Dimopoulos, Meletios A., Huang, Jeffrey SY, Minarik, Jiri, Cavo, Michele, Prince, H. Miles, Zheng, Cheng, Dubin, Franck, Van De Velde, Helgi, Anderson, Kenneth Carl
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Final results of a phase Ib study of isatuximab (ISA) plus pomalidomide (Pom) and dexamethasone (dex) in relapsed/refractory multiple myeloma (RRMM)
Mikhael, Joseph, Richardson, Paul G., Usmani, Saad Zafar, Raje, Noopur S., Bensinger, William, Dubin, Franck, Liu, Qianying, Vitse, Olivier, Anderson, Kenneth Carl
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
OAB-052: Isatuximab plus pomalidomide/low-dose dexamethasone versus pomalidomide/low-dose dexamethasone in patients with relapsed/refractory multiple myeloma (ICARIA-MM): final overall survival analysis
Richardson, Paul, Perrot, Aurore, San-Miguel, Jesus, Beksac, Meral, Špička, Ivan, Leleu, Xavier, Schjesvold, Fredrik, Moreau, Philippe, Dimopoulos, Meletios A., Huang, Jeffrey Shang-Yi, Minarik, Jiri, Cavo, Michele, Prince, H Miles, Malinge, Laure, Dubin, Franck, Morisse, Mony, Anderson, Kenneth
Published in Clinical lymphoma, myeloma and leukemia (01.08.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.08.2022)
Get full text
Journal Article
MM-096: Isatuximab Short-Duration Fixed-Volume Infusion Combination Therapy for Relapsed/Refractory Multiple Myeloma: Final Results of a Phase 1b Feasibility/Safety Study
Usmani, Saad, Karanes, Chatchada, Bensinger, William, D'Souza, Anita, Raje, Noopur, Tuchman, Sascha, Sborov, Douglas, Kanagavel, Dheepak, Saleem, Rao, Dubin, Franck, Campana, Frank, Richardson, Paul
Published in Clinical lymphoma, myeloma and leukemia (01.09.2020)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2020)
Get full text
Journal Article
A phase III randomized, open label, multicenter study comparing isatuximab, pomalidomide, and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM)
Richardson, Paul G., Attal, Michel, Rajkumar, S. Vincent, San Miguel, Jesus, Beksac, Meral, Spicka, Ivan, Leleu, Xavier, Schjesvold, Fredrik, Moreau, Philippe, Dimopoulos, Meletios A., Huang, Jeffrey SY, Minarik, Jiri, Cavo, Michele, Prince, H. Miles, Macé, Sandrine, Corzo, Kathryn Penkus, Campana, Frank, Le-Guennec, Solenn, Dubin, Franck, Anderson, Kenneth Carl
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Preliminary Results from a Phase Ib Study of Isatuximab in Combination with Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma
Richardson, Paul G., Mikhael, Joseph, Usmani, Saad Z, Raje, Noopur, Bensinger, William, Campana, Frank, Gao, Lei, Dubin, Franck, Wack, Claudine, Anderson, Kenneth C.
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Corrigendum to “P-137: ITHACA, A Randomized Multicenter Phase 3 Study of Isatuximab in Combination With Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma: Safety Run-in Preliminary Results” [Clinical Lymphoma Myeloma and Leukemia 21 S2 (2021) S109- S110]
Ghobrial, Irene M., Rodríguez-Otero, Paula, Koh, Youngil, Martínez-López, Joaquín, Parmar, Gurdeep, Prince, Miles, Quach, Hang, de la Rubia, Javier, Hermansen, Emil, Hungria, Vania, Kalayoglu Besisik, Sevgi, Kim, Jin Seok, Leleu, Xavier, Peceliunas, Valdas, Schjesvold, Fredrik, Dubin, Franck, Devisme, Christine, Lepine, Lucie, Macé, Sandrine, Oprea, Corina, Mateos, María-Victoria
Published in Clinical lymphoma, myeloma and leukemia (01.07.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.07.2022)
Get full text
Journal Article